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Abstract
OBJECTIVES: To evaluate the outcome of treatment for deep sternal wound infection (DSWI) in a nationwide patient cohort, before
and after the introduction of negative-pressure wound therapy (NPWT).
METHODS: This was a population-based cohort of all patients treated for DSWI in Iceland out of 2446 open heart operations per-
formed between 2000 and 2010. Length of hospital stay, survival and reoperations were compared in (i) 23 patients treated with open
and/or closed irrigation before August 2005 (conventional treatment, CvT group) and in (ii) 20 patients treated after this time with
NPWT as a ﬁrst-line therapy (NPWT group).
RESULTS: The DSWI rate was 1.8% and did not change during the study period. Demographics were similar for both groups, except for
peripheral arterial disease which was less common in the NPWT group. Coagulase-negative staphylococci were also more common (as
the only pathogen identiﬁed) in the NPWT group (70% vs 30%, P = 0.01). The median length of hospital stay was 43 days in both
groups and the sternum could be closed with delayed primary closure in all except 2 patients, one in each group. Eight patients in the
CvT group required surgical revision for re-infections, including debridement and rewiring, when compared with 1 patient in the
NPWT group (P = 0.02). Furthermore, 6 patients in the CvT group developed late chronic infections of the sternum requiring surgical re-
vision, compared with one in the NPWT group (P = 0.10). The 30-day mortality was not signiﬁcantly different between groups (4% vs
0%, P > 0.1) and the same was true for 1-year mortality (17% vs 0%, P = 0.11).
CONCLUSIONS: NPWT signiﬁcantly reduces the risk of early re-infections in patients with DSWI. There was a lower rate of late chronic
sternal infections and lower mortality in the NPWT group, but the difference was not statistically signiﬁcant. We conclude that NPWT
should be considered as a ﬁrst-line treatment for most DSWIs.
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INTRODUCTION
Deep sternal wound infection (DSWI) following open-heart
surgery is a serious and devastating complication, with an inci-
dence between 1 and 5% in most studies [1, 2]. After convention-
al treatment (CvT), which usually involves surgical revision
followed by open wound dressings with or without wound irri-
gation, mortality of up to 24% has been reported [2, 3].
Furthermore, DSWI is associated with signiﬁcantly increased
morbidity and costs [4], and negative effect on long-term quality
of life [5].
Early and aggressive treatment is the key to effective treat-
ment. However, negative-pressure wound therapy (NPWT) has
been shown to have several advantages over CvT, including
lower in-hospital mortality, improved wound healing and shorter
length of stay (LOS) [2, 3]. Several studies have compared early
outcome of NPWT with that of CvT, but in most of these reports,
information on failure rate, including the need for surgical inter-
vention for re-infections, is missing. However, most of these
studies have involved large tertiary reference centres and thus,
the outcome of NPWT treatment may not be representative of
the general population. NPWT was introduced in Iceland in
August 2005 as a ﬁrst-line therapy for DSWI following open
heart surgery and, subsequently, all patients with DSWI in
Iceland have been treated with NPWT.
†This research was carried out at Landspitali University Hospital, Reykjavík,
Iceland.
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We evaluated the outcome of DSWI in Iceland, using a
population-based registry of all cardiothoracic operations in the
country, before and after the introduction of NPWT. Our main
interest was early and late outcome and the need for surgical
intervention due to early re-infections.
MATERIALS AND METHODS
Landspitali University Hospital is a 750-bed teaching hospital in
Reykjavik, Iceland, the only centre performing cardiac surgery in
the country. During the period 1 January 2000 and 31
December 2010, 43 adults (>18 years) were diagnosed as having
culture-veriﬁed DSWI following open heart surgery. The
National Bioethics Committee and the Icelandic Data Protection
Commission approved the study protocol.
DSWI was deﬁned according to the guidelines from the US
Centers for Disease Control and Prevention (CDC) for post-
sternotomy mediastinitis [6]. An early re-infection was deﬁned as
an infection fulﬁlling the CDC deﬁnition of DSWI that was diag-
nosed after at least one adequate treatment attempt. Late
chronic infections were deﬁned as infections of the sternum that
required surgical intervention, but did not fulﬁl the criteria for
DSWI, and that were diagnosed after discharge from hospital.
Examples of late infections include sternocutaneous ﬁstulas, sub-
cutaneous abscesses, and chronic osteomyelitis. All infections
were culture veriﬁed.
All patients with DSWI were initially treated with intravenous
antibiotics, surgical debridement of necrotic and infected tissue,
and the removal of sternal wires. The patients were divided into
two study groups according to the primary treatment used after
wound debridement (CvT or NPWT).
The CvT group consisted of 23 patients who were treated
between January 2000 and July 2005 with either open dressings
and/or closed irrigation. Open wound dressing treatment con-
sisted of packing of the wound with either parafﬁn or chlorhexi-
dine gauze dressings that were changed twice daily, until
delayed primary closure could be achieved or the skin could be
sutured together to bring the edges of the wound together.
When closed irrigation was performed, two to three chest tubes
were placed in the mediastinum and irrigated with 0.9% saline,
the chest tubes being removed when the wound was no longer
considered to be infected.
The NPWT group included 20 consecutive patients who were
treated after August 2005. In all cases, NPWT was used as a ﬁrst-
line therapy. Following wound debridement, a parafﬁn gauze
dressing was placed at the bottom of the wound to protect the
right ventricle. Subsequently, polyurethane foam was placed in
the wound in two layers (V.A.C.® GranuFoam™; KCI Medical, San
Antonio, TX, USA). A negative pressure of −125 mmHg was
applied using the vacuum-assisted closure system (V.A.C.®; KCI
Medical). After 2–4 days, the wound was reopened and the
foam changed, most often for a total of three times. When the
wound was granulated and there was no sign of infection,
delayed primary closure was performed—or secondary closure
when necessary.
Outcome variables were the rate of early re-infections and
chronic sternal infections, LOS, in-hospital mortality and 1-year
survival.
All patients were followed up 1 week postoperatively by the
surgical team and four times annually by their consultant cardi-
ologist. All patients with complications were treated at our
institution, but 2 patients left the country within 1 year after the
operation. On 1 April 2011, the total length of follow-up was
168 person-years with an average follow-up time of 3.9 ± 3.1
years (range 0.1–10.8). In the CvT group, total follow-up was 123
person-years (average 5.4 ± 3.5 years, range 0.1–10.8) and it was
45 person-years (average 2.2 ± 1.2 years, range 0.4–4.3) in the
NPWT group.
Continuous variables were compared using Student’s unpaired
t-test with approximately normally distributed data, otherwise a
Wilcoxon–Mann–Whitney U-test was used. Categorical variables
were compared using χ2 test or Fisher’s exact test. Outcome vari-
ables with censored data were compared using a log-rank test.
Logistic regression analysis was used to calculate odds ratio and
95% conﬁdence interval for recurrence of DSWI after treatment
with either CvT or NPWT, thereby adjusting for known risk
factors of DSWI, especially peripheral arterial disease and differ-
ent pathogens. Statistical analysis was performed and graphs
were plotted using the STATA software version 10. Two-tailed P
values less than 0.05 were considered signiﬁcant. One-year
crude survival was plotted using the Kaplan–Meier method.
RESULTS
During the 11-year study period, 43 of 2446 open heart surgery
patients (1.8%) were diagnosed with DSWI in Iceland. Mean age
for the whole group of patients was 69 years and 74% were
males. In both groups, coronary artery by-pass grafting (CABG)
alone was the most common procedure (63%), followed by
aortic valve replacement in combination with CABG (16%), and
aortic valve replacement alone (7%). The left internal mammary
artery was used as a bypass conduit in 20 cases (87%) in the CvT
group compared with 15 (75%) in the NPWT group (P = 0.31). An
emergency operation was performed in 2 cases (5%), and there
was bilateral use of the internal mammary arteries in three (7%).
Preoperative characteristics in the CvT and NPWT groups are
presented in Table 1. There were no signiﬁcant differences
between the groups except for peripheral artery disease,
Table 1: Preoperative characteristics of patients with
deep sternal wound infection
Variables NPWT
(n = 20)
Conventional
treatment (n = 23)
P
Age (years) 69 ± 8 69 ± 10 0.89
Female gender 5 (25) 6 (26) 0.86
Obesitya 9 (45) 8 (35) 0.71
Current smoker 9 (45) 10 (43) 0.84
Diabetes mellitus 9 (45) 11 (48) 0.90
Ischaemic heart disease 16 (80) 21 (91) 0.53
Peripheral arterial disease 1 (5) 8 (35) 0.02
COPD 6 (30) 4 (17) 0.47
Renal failure 2 (10) 2 (9) 1
Ejection fraction (<30%) 5 (25) 2 (9) 0.22
NYHA class IV 9 (45) 11 (48) 0.78
EuroSCORE (log) 9.5 ± 9.8 8.7 ± 6.2 0.53
Continuous variables are presented as mean ± standard deviation and
categorical variables are presented as n (%).
BMI: body mass index; COPD: chronic obstructive pulmonary disease;
NYHA: New York Heart Association functional classification.
aObesity is classified as BMI > 30 kg/m2.
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which was more common in the CvT group (P = 0.02).
Coagulase-negative staphylococci were identiﬁed as sole patho-
gen in the CvT group in 7 cases (30%) when compared with 14
(70%) in the NPWT group (P = 0.01). Staphylococcus aureus was
the only pathogen identiﬁed in 10 patients (43%) in the CvT
group and in 4 patients (20%) in the NPWT group (P = 0.10).
Other pathogens or multiple pathogens were identiﬁed in 6
patients (26%) in the CvT group and in 2 patients in the NPWT
group (P = 0.18).
The surgical outcome for both groups is presented in Table 2.
There was no signiﬁcant difference in LOS stay between the CvT
and NPWT groups: 48 ± 23 days (median 43, inter-quartile range
32–60) and 47 ± 17 days (median 43, inter-quartile range 34–60),
respectively (P = 0.84). The same was true for ICU stay, 4.3 ± 7.4
days (median 1, inter-quartile range 0–5) when compared with 3.7
± 7.6 days (median 1, inter-quartile range 0–4) for the CvT and
NPWT groups, respectively (P = 0.81). One patient in the CvT group
died during treatment, whereas none died in the NPWT group.
Early re-infection was diagnosed in 9 patients (21%), 8 (35%) in
the CvT group and one (5%) in the NPWT group (P = 0.02)
(Table 3). The time from the primary operation to surgical treatment
for re-infection was 47 ± 41 days (median 35; inter-quartile range
24–48). In the CvT group, 5 patients had originally been treated
with closed irrigation and three with open wound dressing. The
only patient with persistent DSWI in the NPWT group was found to
have a Pseudomonas aeruginosa infection, which was cultured from
both the wound and the sponge. NPWT treatment was discontin-
ued and acetic acid wound dressing used successfully, which made
rewiring of the sternum, without tissue ﬂap surgery, possible.
Late chronic sternal wound infections requiring surgical treat-
ment developed in 1 patient in the NPWT group and in 6
patients in the CvT group (including 3 patients who were treated
for persistent DSWI), but the difference was not statistically sig-
niﬁcant (P = 0.10). The same was true for 1-year survival in the
two groups (Fig. 1).
There were three intraoperative complications. In the NPWT
group, a bleeding from the heart that was not life-threatening
occurred in 2 cases, but there was no complete rupture of
the right ventricle. In both cases, direct suture with patch was
performed without the need for cardiopulmonary by-pass. In
the CvT group, 1 patient with a recurrent DSWI had a rupture of
the right ventricle when the sternal wound was reopened, which
resulted in a fatal intraoperative bleeding.
Table 2: Surgical treatment outcome of deep sternal
wound infection for patients treated with NPWT and by
conventional means
Variables NPWT
(n = 20)
Conventional
treatment
(n = 23)
P
Early outcome
Re-infection 1 (5) 8 (35) 0.02
Median LOS in
hospital (days)
43.0 43.0 0.39
In-hospital mortality 0 (0) 1 (4) 1
Late outcome
Late infection 1 (5) 6 (27) 0.07
1-year mortality 0 (0) 4 (17) 0.07
Variables are presented as n (%) except where otherwise specified.
DSWI: deep sternal wound infection; LOS: length of stay.
Table 3: Patients who were treated surgically for early re-infections following treatment for deep sternal wound infection
Case Age/sex/operation Pathogen POD Risk factors Treatment for recurrent
DSWI
Outcome
Conventional treatment group—Closed irrigation (cases no. 1–5) or open wound dressings (cases no. 6–8)
1 57/M/CABG Staphylococcus aureus 19 DM I, obesity,
transplanted kidney
Closed irrigation Primary closure
2 64/M/CABG S. aureus, Enterococcus faecalis,
Klebsiella pmeumoniae,
Haemophilus influenzae
23 – Open wound dressing for
26 days in ICU
Omental flap closure
with closed
irrigation
3 84/M/CABG + AVR CoNS 24 – Closed irrigation Primary closure
4 70/M/CABG + AVR S. aureus 31 PAD, smoking Open dressing changes Secondary closure
5 58/M/CABG S. aureus 48 Smoking Closed irrigation Primary closure with
a steel plate
6 58/M/CABG + AVR CoNS 39 COPD, DM I, PAD,
chronic renal failure
Closed irrigation Primary closure
7 64/M/CABG S. aureus 49 DM II Open dressing changes Primary closure
8 72/F/CABG S. aureus 153 PAD Intraoperative death due to
bleeding
Death due to
rupture of right
ventricle
Negative-pressure wound therapy group
9 54/F/CABG CoNS + Pseudomonas
aeruginosa
35 DM II, obesity NPWT for 3 weeks but
treatment changed
successfully to acetic
acid wound dressings
Primary closure
AVR: aortic valve replacement; CABG: coronary artery by-pass graft; CoNS: coagulase-negative staphylococci; COPD: chronic obstructive pulmonary
disease; DM: diabetes mellitus; DSWI: deep sternal wound infection; F: female; M: male; PAD: peripheral arterial disease; POD: postoperative days to
treatment of re-infection.
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DISCUSSION
This study shows that DSWI treated with NPWT is associated
with a signiﬁcantly lower rate of early re-infections requiring
surgical revision. The rate of early re-infections in the CvT
group and in the NPWT group corresponds well with other
reports of comparison of NPWT and CvT, most of them
showing around 25% lower absolute risk of re-infections fol-
lowing NPWT [3, 7, 8].
Not all studies have shown a lower rate of surgical reinterven-
tion following NPWT for DSWI [9]. Bapat et al. (2008) reported
that patients treated with long-term NPWT had a higher risk of
recurrence than those with primary closure [10]. In these studies,
NPWT was used as the only treatment and no primary closure of
the wound was performed. In our opinion, one of the major
strengths of NPWT is the facilitation of delayed primary closure,
as the sternum and adjacent tissue are well preserved. Although
coagulase-negative staphylococci were more common in the
NPWT group, the risk of early re-infections could not be related
to that ﬁnding exclusively. This is important as these pathogens
may not be as aggressive as pathogens such as S. aureus in this
setting. Furthermore, the rate of methicillin-resistant S. aureus
infections in Iceland has been low and has remained low
throughout the period [11].
Late chronic infections of the sternum can arise both as
primary infections and following DSWI, and often result in nu-
merous surgical procedures [12]. Although the difference was not
statistically signiﬁcant, there appeared to be a trend of fewer late
infections following NPWT (Table 2). Previous studies have
shown that up to 90% of these infections are diagnosed within
the ﬁrst year, and the effect of a shorter follow-up in the NPWT
group should therefore be minimal [12].
There was not a signiﬁcant difference in the LOS between
groups. There are conﬂicting results regarding LOS following
NPWT, some studies suggesting shorter LOS [7] while other
studies similar [3, 8].
One in-hospital death occurred in the CvT group when
compared with none in the NPWT group. Our results suggest
that early and late mortality following both CvT and NPWT for
DSWI is low [1]. Several recent reports have shown that NPWT
is associated with low DSWI mortality, both early (as low as
1.1%) and late [2, 13, 14]. This is important, since early mortal-
ity as high as 24% following CvT has been reported [2, 3].
However, there may be other explanations for this reduced
mortality after treatment for DSWI, e.g. improved intensive
care or sepsis treatment.
Signiﬁcant bleeding from the wound occurred in 3 cases (7%).
This is a known complication of both DSWI and NPWT, which
might be prevented in most cases with careful surgical techni-
ques [14].
To the best of our knowledge, this is the ﬁrst study to
compare historically CvT and NPWT in a nationwide cohort of
patients, thus minimizing the effects of referral bias on the
outcome of treatment. We believe that further studies of failure
rate and mortality rate in larger patient cohorts are warranted.
Limitations
The most important limitation of the study is that the groups
were relatively small, which may have an effect on the analysis
regarding both operative mortality and hospital stay.
Conclusion
NPWT seems to signiﬁcantly reduce the risk of early re-infections
in patients with DSWI. We think NPWT should be considered as
a ﬁrst-line treatment for most DSWIs.
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We read with great interest the article by Steingrimsson et al. regarding the efﬁ-
ciency of vacuum-assisted closure (VAC) therapy for deep sternal wound infections
(DSWI) in cardiac surgery [1]. The deﬁnition of DSWI as documented by the US
Centers for Disease Control is an ‘infection involving fascia or deeper with at least
one of the following: evidence of infection seen at re-operation or spontaneous
dehiscence, positive culture of mediastinal ﬂuid and/or positive blood culture and/
or chest pain with sternal instability and temperature higher than 38°C [2].’
VAC therapy has now become a standard method of treatment for DSWI. In a
prospective randomized trial by Moues and colleagues in 2004, a signiﬁcant reduc-
tion in the wound surface area was noted in the VAC group compared to the con-
ventional moist gauze therapy [3.8 ± 0.5 percent/day (mean ± SEM) vs 1.7 ± 0.6
percent/day respectively; p < 0.05]. However, the superiority of VAC therapy could
not be explained by a signiﬁcant reduction in the bacterial load [3].
In the retrospective cohort study by Gdalevitch and colleagues, the predictive
factors identiﬁed for VAC treatment failure were the positive blood cultures (most
sensitive predictor), wound depth of more than 4 cm (most speciﬁc predictor) and
a high degree of sternal exposure and instability. Furthermore, the authors have
suggested that these patients might be better managed by a surgical approach [4].
Luckraz and colleagues, in 2003, suggested that VAC therapy used alone or com-
bined with other surgical modalities can offer acceptable results for the treatment
of DSWI in cardiac surgery. In addition, the total cost for the hospitalization and
treatment for patients in the VAC group was $16 400 per patient, compared with
$20 000 per patient in the sternal rewiring and closed irrigation treatment group
[5].
In conclusion, VAC therapy is an acceptable method for the treatment of DSWI.
Patients with these devastating and potentially life-threatening complications can
be assessed on an individual basis by an experienced team of cardiothoracic
surgeons.
Conﬂict of interest: none declared.
References
[1] Steingrimsson S, Gottfredsson M, Gudmundsdottir I, Sjögren J, Gudbjartsson
T. Negative-pressure wound therapy for deep sternal wound infections
reduces the rate of surgical interventions for early re-infections. Interact
CardioVasc Thorac Surg 2012;15:406–10.
[2] Bruce J, Russell E, Mollison J, Krukowski Z. The measurement and monitoring
of surgical adverse events. Health Technol Assess 2001;5:1–194.
[3] Moues C, Vos M, Van den Bemd G, Stijnen T, Hovius S. Bacterial load in rela-
tion to vacuum-assisted closure wound therapy: a prospective randomized
trial. Wound Repair Regen 2004;12:11–7.
[4] Gdalevitch P, Aﬁlalo J, Lee C. Predictors of vacuum-assisted closure failure of
sternotomy wounds. J Plast Reconstr Aesthet Surg 2010;63:180–3.
[5] Luckraz H, Murphy F, Bryant S, Charman SC, Ritchie AJ. Vacuum-assisted
closure as a treatment modality for infections after cardiac surgery. J Thorac
Cardiovasc Surg 2003;125:301–5.
eComment. A change in the microbial spectrum in deep sternal wound
infections
Author: Jan J. van Wingerden
Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
doi:10.1093/icvts/ivs375
© The Author 2012. Published by Oxford University Press on behalf of the
European Association for Cardio-Thoracic Surgery. All rights reserved.
I read the article by Steingrimsson et al. with interest [1].
Since the introduction of negative-pressure wound therapy in the management
of deep sternal wound infection (DSWI) in 1999, various centres, albeit without ab-
solute comparable study populations, have reported an alarming increase in the in-
cidence of the deceptive coagulase-negative Staphylococcus (CoNS) as the major
causative organism [2]. This elegant study by Steingrimsson and colleagues supports
the concern. They identiﬁed CoNS as the sole pathogen in 70% of cases with DSWI
between 2005–2010, when compared to 30% between 2000–2005 (p = 0.01). Up to
2007, Staphylococcus aureus and/or CoNS were the most prevalent pathogens
encountered in DSWI [3]. Recently in 2009, Ennker et al. and Eriksson et al.
reported a CoNS incidence of 38% and 62% in their single-institution case-series of
DSWI, respectively. One could be forgiven in thinking this to be a purely Nordic
phenomenon – this is not the case. In their study over a period of 15 years, Matros
and colleagues [4] found CoNS, cultured in 49% of 285 sternal wounds, to be the
most prevalent pathogen. Patients with CoNS-related DSWI may present late (> 3
weeks), with less obvious symptoms and less pronounced infective markers (C-re-
active protein, white blood cell count). Furthermore, these patients are often
afﬂicted with diabetes mellitus, chronic obstructive pulmonary disease (COPD) or
suffer from obesity. According to some, methicillin-resistance of the Staphylococci
can be above 90% in DSWI associated with CoNS. Fortunately, as Steingrimsson
and colleagues point out, the incidence of MRSA in Iceland has remained low.
A point of further interest is that bleeding occurred in both groups [1]. As
expounded elsewhere, the exact relation to negative-pressure wound therapy has
yet to be clariﬁed [5].
Note: complete list of references is available from the author.
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